153 related articles for article (PubMed ID: 1703960)
1. Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration.
Michaelsen TE; Garred P; Aase A
Eur J Immunol; 1991 Jan; 21(1):11-6. PubMed ID: 1703960
[TBL] [Abstract][Full Text] [Related]
2. Interaction of K lymphocytes with myeloma proteins of different IgG subclasses.
Spiegelberg HL; Perlmann H; Perlmann P
J Immunol; 1976 Nov; 117(5 Pt 1):1464-71. PubMed ID: 1002986
[TBL] [Abstract][Full Text] [Related]
3. Structural difference in the complement activation site of human IgG1 and IgG3.
Michaelsen TE; Sandlie I; Bratlie DB; Sandin RH; Ihle O
Scand J Immunol; 2009 Dec; 70(6):553-64. PubMed ID: 19906198
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG immune complexes and in specific granule release induced by soluble IgG immune complexes.
Voice JK; Lachmann PJ
Eur J Immunol; 1997 Oct; 27(10):2514-23. PubMed ID: 9368604
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.
Dhein J; Daniel PT; Trauth BC; Oehm A; Möller P; Krammer PH
J Immunol; 1992 Nov; 149(10):3166-73. PubMed ID: 1431095
[TBL] [Abstract][Full Text] [Related]
6. Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis.
Brekke OH; Michaelsen TE; Aase A; Sandin RH; Sandlie I
Eur J Immunol; 1994 Oct; 24(10):2542-7. PubMed ID: 7925582
[TBL] [Abstract][Full Text] [Related]
7. Neutralization capacity and antibody dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex virus.
Mathiesen T; Persson MA; Sundqvist VA; Wahren B
Clin Exp Immunol; 1988 May; 72(2):211-5. PubMed ID: 2842096
[TBL] [Abstract][Full Text] [Related]
8. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
Lucisano Valim YM; Lachmann PJ
Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
[TBL] [Abstract][Full Text] [Related]
9. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies.
Lohse S; Peipp M; Beyer T; Valerius T; Dechant M
Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):303-12. PubMed ID: 20508996
[TBL] [Abstract][Full Text] [Related]
10. The IgG subclass pattern of complement activation depends on epitope density and antibody and complement concentration.
Garred P; Michaelsen TE; Aase A
Scand J Immunol; 1989 Sep; 30(3):379-82. PubMed ID: 2476845
[TBL] [Abstract][Full Text] [Related]
11. IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.
Mayumi M; Kuritani T; Kubagawa H; Cooper MD
J Immunol; 1983 Feb; 130(2):671-7. PubMed ID: 6217248
[TBL] [Abstract][Full Text] [Related]
12. IgG antibody subclasses in human filariasis. Differential subclass recognition of parasite antigens correlates with different clinical manifestations of infection.
Hussain R; Grögl M; Ottesen EA
J Immunol; 1987 Oct; 139(8):2794-8. PubMed ID: 3309059
[TBL] [Abstract][Full Text] [Related]
13. A genetically engineered human IgG mutant with enhanced cytolytic activity.
Shopes B
J Immunol; 1992 May; 148(9):2918-22. PubMed ID: 1573276
[TBL] [Abstract][Full Text] [Related]
14. Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
Bergamaschini L; Santangelo T; Faricciotti A; Ciavarella N; Mannucci PM; Agostoni A
J Immunol; 1996 Feb; 156(3):1256-61. PubMed ID: 8558005
[TBL] [Abstract][Full Text] [Related]
15. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
16. Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region.
Michaelsen TE; Aase A; Norderhaug L; Sandlie I
Mol Immunol; 1992 Mar; 29(3):319-26. PubMed ID: 1557042
[TBL] [Abstract][Full Text] [Related]
17. Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.
Smith RI; Coloma MJ; Morrison SL
J Immunol; 1995 Mar; 154(5):2226-36. PubMed ID: 7868896
[TBL] [Abstract][Full Text] [Related]
18. Mediation of cytotoxic functions by classes and subclasses of sheep antibody reactive with cell surface immunoglobulin idiotypic and constant region determinants.
Stevenson FK; Elliott EV
Immunology; 1978 Feb; 34(2):353-8. PubMed ID: 75184
[TBL] [Abstract][Full Text] [Related]
19. IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens.
Kuijpers TW; Weening RS; Out TA
Allergol Immunopathol (Madr); 1992; 20(1):28-34. PubMed ID: 1509985
[TBL] [Abstract][Full Text] [Related]
20. Flexibility of human IgG subclasses.
Roux KH; Strelets L; Michaelsen TE
J Immunol; 1997 Oct; 159(7):3372-82. PubMed ID: 9317136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
